🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

19 recruiting trials

for IrAE

Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial NCT06470971Phase 21 site📍 Columbus Yuanquan Yang · Tests: Anti-PD-L1 Monoclonal Antibody, Anti-PD1 Monoclonal Antibody, Biopsy, Biospecimen Collection, Bone Scan Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer NCT06613165n/a1 site📍 Xi'an Xijing Hospital Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment NCT05813418NA1 site📍 Amiens Centre Hospitalier Universitaire, Amiens · Tests: blood retriewal Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository NCT06789601Phase 1, Phase 22 sites📍 Boston📍 Boston Brigham and Women's Hospital · Tests: Informatics system for eligibility monitoring, Standard eligibility monitoring Vedolizumab for the Prevention of ICI Related Diarrhea or Colitis in Patients With Cancer NCT06337695Phase 2, Phase 32 sites📍 Calgary📍 Edmonton AHS Cancer Control Alberta · Tests: Vedolizumab, Placebo Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo) NCT05663775Phase 21 site📍 Edmonton AHS Cancer Control Alberta · Tests: Mesalamine Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis NCT06860542Phase 21 site📍 Calgary AHS Cancer Control Alberta · Tests: Arm 2- Budesonide (Pulmicort® Turbuhaler®) + Usual care, Arm 1- Usual care The Effect of Serum Ferritin in irAE NCT06702566NA1 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: PD-1 and PD-L1 inhibitor, Targeted drugs, chemotherapy drugs A Clinical and Biological Prospective Database of Patients Treated With Anticancer Immunotherapy and Follow up of Their Immune-related Adverse Events irAE NCT03989323n/a5 sites📍 Bron📍 Bron📍 Lyon Hospices Civils de Lyon · Tests: Estimation of the incidence of the irAE Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy NCT06461780n/a1 site📍 Taipei Taipei Veterans General Hospital, Taiwan Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma NCT07644897Phase 22 sites📍 Guangzhou📍 Shenzhen Sun Yat-sen University · Tests: Thymosin Alpha 1 and Anti-PD-1 monoclonal antibody Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors NCT05799898n/a1 site📍 Paris Institut Mutualiste Montsouris · Tests: No intervention for research purposes only The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities NCT07381634Phase 21 site📍 Wenzhou First Affiliated Hospital of Wenzhou Medical University · Tests: ondansetron A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications. NCT06635954n/a3 sites📍 Norwich📍 Dublin📍 Rock Hill Oxford Biodynamics Inc. Food Intervention to Reduce Immunotherapy ToXicity NCT05832606NA1 site📍 Jette Universitair Ziekenhuis Brussel · Tests: Food box containing 30 different plants Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis NCT06037811Phase 21 site📍 London Tom Appleton · Tests: Adalimumab, Prednisone SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr) NCT06278857Phase 23 sites📍 Sydney📍 Brisbane📍 Melbourne Queensland Centre for Gynaecological Cancer · Tests: Dostarlimab-Gxly 50 MG/1 ML Intravenous Solution [JEMPERLI] Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor Therapy NCT07663422Phase 21 site📍 Philadelphia Fox Chase Cancer Center · Tests: Mycophenolate Mofetil plus prednisone Rituximab for Treatment of Checkpoint Inhibitor Induced Immune-related Adverse Events NCT07694414Phase 11 site📍 Herlev Inge Marie Svane · Tests: Rituximab (RTX)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy